Candidiasis (Vulvovaginal)
NICE CKS Candida – female genital. Last revised: Oct 2023.
BASHH Vulvovaginal Candidiasis 2019. Last updated: Jan 2021.
Background Information
Definitions
Vulvovaginal candidiasis (genital thrush): symptomatic inflammation of the vagina and/or vulva secondary to fungal infection.
Recurrent infection: ≥4 symptomatic episodes in 1 year, at least 2 confirmed by microscopy / culture (at least one by culture)
Causative Agent
Most common genus: Candida yeasts
- Most common species: Candida albicans (80-89% cases)
- Candida glabrata (5%)
Risk Factors
- Local irritants – douching, soaps, shampoos, shower gels
- Recent antibiotic use (within 3 months)
- Immunosupression
- Poorly controlled diabetes mellitus
- HIV infection
- Long-term corticosteroid use
- Oestrogen exposure
- Pregnancy
- COCP
- HRT
Clinical Features
Possible symptoms:
- Vulval / vaginal itching (most common), soreness and irritation
- Superficial dyspareunia and dysuria
On examination:
- White ‘cheese-like’ discharge (non-malodorous)
- Erythema
- Vaginal fissuring and/or oedema
- Excoriations
- Satellite lesions (often associated with more severe/extensive disease)
Guidelines
Investigation and Diagnosis
Clinical diagnosis is usually sufficient in the presence of typical signs and symptoms.
Consider the following for recurrent infection / diagnostic uncertainty:
- High vaginal swab of vaginal secretions for microscopy
- Self-collected low vulvovaginal swab is also appropriate (if examination of external genitalia not possible or not needed)
- Culture might be needed for recurrent infection
- Vaginal pH testing of secretions
- Normal pH (<4.5) supports candidiasis
- Not needed for diagnosis, but helpful to exclude bacterial vaginosis and trichomoniasis
- Midstream sample of urine
- If UTI is suspected
- HbA1c – to exclude diabetes mellitus (esp. if recurrent infections)
Management
Acute Infection
Choice of anti-fungal (both oral and topical treatment gives similar cure rates):
- 1st line: oral fluconazole 150mg single dose
- 2nd line: topical clotrimazole 500mg intravaginal pessary single dose
If there are vulval symptoms: consider adding topical clotrimazole 1% / 2% cream 2-3 times a day
Treatment Failure
Definition: if no response to initial treatment within 7-14 days
- Perform a high vaginal swab
- Treat according to high vaginal swab results
Recurrent Infection
Offer an induction-maintenance regimen:
- Induction: 3 doses of oral fluconazole 150mg – to be taken every 72 hours
- Maintenance: oral fluconazole 150mg once a week for 6 months
2nd line induction-maintenance regimen:
- Induction: topical clotrimazole 500mg intravaginal pessary up to 7-14 days
- Maintenance: topical clotrimazole 500mg intravaginal pessary once a week for 6 months OR oral itraconazole 50-100mg daily for 6 months
Infection During Pregnancy
Choice of anti-fungal:
- 1st line: topical clotrimazole intravaginal pessary at night for up to 7 consecutive nights
If there are vulval symptoms: consider adding topical clotrimazole 1% / 2% cream 2-3 times a day
Oral fluconazole and itraconazole are both contraindicated in pregnancy.
Topical antifungals are safe alternatives in pregnancy.
References